Fujian Wanchen Biotechnology Group Co., Ltd. Stock

Equities

300972

CNE100004KH1

Fishing & Farming

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
27.06 CNY -1.60% Intraday chart for Fujian Wanchen Biotechnology Group Co., Ltd. +8.02% -27.92%
Sales 2024 * 20.49B 2.83B Sales 2025 * 23.96B 3.31B Capitalization 4.66B 644M
Net income 2024 * 190M 26.22M Net income 2025 * 359M 49.55M EV / Sales 2024 * 0.23 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.19 x
P/E ratio 2024 *
24.6 x
P/E ratio 2025 *
13 x
Employees 1,670
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.27%
More Fundamentals * Assessed data
Dynamic Chart
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Fujian Wanchen Biotechnology Co., Ltd are subject to a Lock-Up Agreement Ending on 19-APR-2024. CI
Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd Announces Management Appointments CI
Fujian Wanchen Biotechnology Co., Ltd has Changed its Name to Fujian Wanchen Biotechnology Group Co., Ltd CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Fujian Wanchen Biotechnology Co., Ltd announced that it expects to receive CNY 200 million in funding CI
Nanjing Wanpin Commercial Management Co., Ltd. announced that it expects to receive CNY 7 million in funding from Fujian Wanchen Biotechnology Co., Ltd, Huainan Shengyu Enterprise Management Co., Ltd, Huainan Huixiang Enterprise Management Co., Ltd., Xinghua Dewen Management Consulting Co., Ltd., Xinghua Geometry Management Consulting Co., Ltd., and other investors CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 06 June 2022 CI
Fujian Wanchen Biotechnology Co., Ltd Announces Dividend for 2021 CI
More news
1 day-1.60%
1 week+8.02%
Current month-6.79%
1 month-9.35%
3 months-22.11%
6 months-25.19%
Current year-27.92%
More quotes
1 week
24.38
Extreme 24.38
27.79
1 month
23.80
Extreme 23.8
30.67
Current year
23.80
Extreme 23.8
38.05
1 year
23.80
Extreme 23.8
47.53
3 years
10.19
Extreme 10.19
47.53
5 years
10.19
Extreme 10.19
47.53
10 years
10.19
Extreme 10.19
47.53
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 14-06-09
Director of Finance/CFO 53 17-06-08
Director/Board Member 41 14-06-09
Members of the board TitleAgeSince
Director/Board Member 52 23-09-21
Chairman 56 14-06-09
Director/Board Member 31 17-01-24
More insiders
Date Price Change Volume
24-04-26 27.06 -1.60% 1,412,562
24-04-25 27.5 -0.58% 1,345,562
24-04-24 27.66 +5.81% 2,178,394
24-04-23 26.14 -0.19% 1,908,831
24-04-22 26.19 +4.55% 2,657,723

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Fujian Wanchen Biotechnology Group Co Ltd, formerly Fujian Wanchen Biotechnology Co Ltd, is a China-based company mainly engaged in the research and development, factory cultivation and sales of fresh edible fungi. The Company's edible fungi products include enoki mushrooms and real shimeji mushrooms such as crab-flavored mushrooms, white jade mushroom and seafood mushrooms. The Company also distributes bacteria residue. The Company mainly distributes its products within domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
27.06 CNY
Average target price
28.61 CNY
Spread / Average Target
+5.73%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300972 Stock